Speakers

Prof. David Grainger 

University of Utah

University Distinguished Professor and Chair, Department of Bioengineering 
Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry 
Adjunct Professor, Department of Orthopedics 
Adjunct Professor, Department of Chemistry
Professor

 

Research Interests: 

• Drug delivery systems and novel formulation strategies 
• Polymeric biomaterials 
• Antimicrobial medical devices, infection and bacterial colonization 
• Nucleic acid and protein microarray diagnostics 
• Macrophage interactions with biomaterials and the foreign body response 
• Novel live vaccine and protein delivery 
• Bioanalytical sensing and device miniaturization 
• Surface analysis 
 

Prof. Sarah Heilshorn

Stanford University

 

Associate Professor, Materials Science and Engineering

 

Bio: Heilshorn's interests include biomaterials in regenerative medicine, engineered proteins with novel assembly properties, microfluidics and photolithography of proteins, and synthesis of materials to influence stem cell differentiation. Current projects include tissue engineering for spinal cord and blood vessel regeneration, designing injectable materials for use in stem cell therapies, and the design of microfluidic devices to study the directed migration of cells (i.e., chemotaxis).

Dr. Scott Kennedy

Verily Life Sciences (Alphabet Inc.)

 

 

Dr. Scott Kennedy is a research scientist at Verily Life Sciences (formerly Google Life Sciences). His research focuses on development of two types of smart contact lens devices: (1) a glucose sensing contact lens for diabetic patients and (2) an accommodating contact lens for people with presbyopia. He received his PhD in Polymer Science Engineering from University of Massachusetts, Amherst. Dr. Kennedy was a professor at Anderson University for nearly 13 years prior to joining Verily in 2014. 

 

Verily aspires to create a world in which technology and life sciences are not distinct, but partners with a united mission. Formerly Google Life Sciences, Verily's mission is to bring together technology and life sciences to uncover new truths about health and disease. Verily's multidisciplinary teams have access to advanced research tools, large-scale computing power, and unique technical expertise. They work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies.

Prof. Niren Murthy

University of California, Berekely

University Distinguished Professor and Chair, Department of Bioengineering 
Professor in the Department of Bioengineering at the University of California at Berkeley

 

Research Interests: 

Our laboratory is broadly focused on developing new molecules and materials for molecular imaging and drug delivery. Recent projects in the lab include the development of new probes for in vivo imaging of bacterial infections and reactive oxygen species.   In addition, we also have a long standing interest in developing new materials for intracellular protein delivery. 

Drisha Leggitt

Chief Marketing Officer 
Anpac Bio
 
 
Ms. Leggitt is an internationally recognized public relations and marketing professional who has led marketing and PR nationally and internationally for major technology companies, including Hewlett-Packard, Agilent Technologies, and LCS Technologies. As a proud member of the Anpac Bio’s leadership team, she leads partnership and investment development, communications and marketing, and external affairs. She enjoys applying her professional skills to educate the public and potential Anpac partners about Anpac Bio’s cutting-edge Cancer Differentiation Analysis (CDA) technology, saving lives worldwide.
 
Anpac Bio-Medical Science Company, Ltd., is led by award-winning and internationally respected biomedical and nanotechnology scientists, research and medical professionals, engineering experts and physicists -- creating and launching break-through, leading edge, early cancer and other disease screening, detection, and diagnostic technology.
 

Dr. Kate Stuart 

Senior Director Translational Biology 
Symic Bio
 
 
Dr. Stuart has over 10 years of experience in research and development in the life science field, and is an inventor of Symic’s core technology. After receiving a PhD degree in biomedical engineering from Purdue University, she continued at Purdue in a post-doc focused on early translation of the proteoglycan mimics. Previous to helping found Symic, Dr. Stuart worked in mid to late stage startup companies as a scientist and consultant on multiple marketed extracellular matrix technologies. She has served as PI on 5 small business grant awards.

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The (extracellular) matrix is the non-cellular component of the body’s tissues and can be envisioned as a sponge-like environment surrounding the cells of a tissue. In this environment, cells proliferate, migrate and differentiate. Research in recent decades has demonstrated the biological importance of the interactive and dynamic relationship between cells and their matrix environment. The Symic Bio platform of matrix-targeting biotherapeutics builds upon this research. These therapeutics, inspired by naturally occurring macromolecules of the matrix called proteoglycans, bind to targets in the matrix damaged in response to injury or because of disease. They are designed to inhibit pathological inflammatory responses and to affect matrix degradation and structure.

Dr. Kate Stuart 

University of California, Berekely

University Distinguished Professor and Chair, Department of Bioengineering 
Professor in the Department of Bioengineering at the University of California at Berkeley

Research Interests: 

Our laboratory is broadly focused on developing new molecules and materials for molecular imaging and drug delivery. Recent projects in the lab include the development of new probes for in vivo imaging of bacterial infections and reactive oxygen species.   In addition, we also have a long standing interest in developing new materials for intracellular protein delivery. 

Prof. Niren Murthy

University of California, Berekely

University Distinguished Professor and Chair, Department of Bioengineering 
Professor in the Department of Bioengineering at the University of California at Berkeley

Research Interests: 

Our laboratory is broadly focused on developing new molecules and materials for molecular imaging and drug delivery. Recent projects in the lab include the development of new probes for in vivo imaging of bacterial infections and reactive oxygen species.   In addition, we also have a long standing interest in developing new materials for intracellular protein delivery.